- Home
- MNOV vs ANIX Comparison
MNOV vs ANIX Comparison
Compare MNOV & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- ANIX
- Stock Information
- Founded
- MNOV 2000
- ANIX 1982
- Country
- MNOV United States
- ANIX United States
- Employees
- MNOV N/A
- ANIX N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- MNOV Health Care
- ANIX Health Care
- Exchange
- MNOV Nasdaq
- ANIX Nasdaq
- Market Cap
- MNOV 87.5M
- ANIX 84.7M
- IPO Year
- MNOV 2005
- ANIX 1987
- Fundamental
- Price
- MNOV $1.47
- ANIX $2.81
- Analyst Decision
- MNOV Strong Buy
- ANIX Strong Buy
- Analyst Count
- MNOV 1
- ANIX 2
- Target Price
- MNOV $9.00
- ANIX $8.50
- AVG Volume (30 Days)
- MNOV 18.3K
- ANIX 93.0K
- Earning Date
- MNOV 05-08-2025
- ANIX 03-11-2025
- Dividend Yield
- MNOV N/A
- ANIX N/A
- EPS Growth
- MNOV N/A
- ANIX N/A
- EPS
- MNOV N/A
- ANIX N/A
- Revenue
- MNOV N/A
- ANIX N/A
- Revenue This Year
- MNOV N/A
- ANIX N/A
- Revenue Next Year
- MNOV N/A
- ANIX N/A
- P/E Ratio
- MNOV N/A
- ANIX N/A
- Revenue Growth
- MNOV N/A
- ANIX N/A
- 52 Week Low
- MNOV $1.12
- ANIX $2.07
- 52 Week High
- MNOV $2.55
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- MNOV 29.19
- ANIX 47.21
- Support Level
- MNOV $1.45
- ANIX $2.58
- Resistance Level
- MNOV $1.66
- ANIX $2.97
- Average True Range (ATR)
- MNOV 0.07
- ANIX 0.20
- MACD
- MNOV -0.02
- ANIX -0.04
- Stochastic Oscillator
- MNOV 5.00
- ANIX 40.35
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.